![Stig Lennart Hansson](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Stig Lennart Hansson
Fondateur chez
CINCLUS PHARMA HOLDING AB
Fortune : 1 M $ au 31/05/2026
Profil
Stig Lennart Hansson is the founder of Sixera Pharma AB, holding the title of Chairman since 2013.
Dr. Hansson is the founder of Cinclus Pharma Holding AB, holding the title of Chairman since 2020.
Dr. Hansson is currently the Chairman of Ignitus AB. Dr. Hansson is currently the Chairman of QureTech Bio AB. Dr. Hansson is currently an Independent Director at Medivir AB since 2018.
Dr. Hansson is currently the Director of HVR Cardio Oy.
Dr. Hansson is currently the Director of InDex Diagnostics AB since 2011.
Dr. Hansson is currently the Director of Beacon Software, Inc. (New York).
Dr. Hansson is currently an Independent Director at InDex Pharmaceuticals AB since 2011.
Former positions include Chief Executive Officer at Arexis AB, Director at CMC Contrast AB, Director at Athera Biotechnologies AB, Independent Non-Executive Director at Calliditas Therapeutics AB, Director at Uminova Invest AB, Director at Nanoxis AB, Director at OxThera AB, Deputy Director at Medtentia AB, Director at Lund University Bioscience AB, Director at Avaris AB, Director at PharmaSurgics In Sweden AB, Deputy Director at Airsonett Holding AB, Director at Malmö Industrifinans AB, Independent Director at Flerie AB, Principal at AstraZeneca AB, Senior Advisor at Industrifonden from 2016 to 2019, Vice President at Biovitrum AB, Investment Manager at Karolinska Development AB (Private Equity), Principal at Kabigen AB, Principal at Karolinska Development AB in 2008, Principal at Symbicom AB, and Member-Supervisory Board at Cinclus Pharma AG.
Education includes a doctorate from Umea Universitet.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 31/12/2025 | 1 084 771 ( 2,33 % ) | 1 M $ | 31/05/2026 |
Postes actifs de Stig Lennart Hansson
| Sociétés | Poste | Début |
|---|---|---|
| MEDIVIR AB | Directeur/Membre du Conseil | 03/05/2018 |
| CINCLUS PHARMA HOLDING AB | Fondateur | 01/01/2014 |
Sixera Pharma AB
 Sixera Pharma AB Pharmaceuticals: GenericHealth Technology Conducts research and development of pharmaceuticals treatment for Netherton syndrome | Fondateur | 01/01/2013 |
Ignitus AB | Président | - |
InDex Diagnostics AB
 InDex Diagnostics AB Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Directeur/Membre du Conseil | 01/01/2011 |
InDex Pharmaceuticals AB
 InDex Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Directeur/Membre du Conseil | 01/01/2011 |
Beacon Software, Inc. /NY/
 Beacon Software, Inc. /NY/ Packaged SoftwareTechnology Services Develops software for transportation agencies | Directeur/Membre du Conseil | - |
HVR Cardio Oy (Finland)
 HVR Cardio Oy (Finland) Medical SpecialtiesHealth Technology Develops medical solutions for mitral valve repair | Directeur/Membre du Conseil | 13/08/2010 |
QureTech Bio AB | Président | - |
Anciens postes connus de Stig Lennart Hansson
| Sociétés | Poste | Fin |
|---|---|---|
| ░░░░░░░░░░░░░░ | ░░░░░░░░ ░░ ░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░░░░░░░░░ ░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░ ░░░░░░░░░░ ░░░░░░░░░░ ░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░ ░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░░░░░░░░ ░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
Formation de Stig Lennart Hansson
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
63
Relations au 1er degré
32
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 32 |
|---|---|
CMC Contrast AB
 CMC Contrast AB Pharmaceuticals: MajorHealth Technology develops magnetic resonance contrast agents for patients suffering with tumors | Health Technology |
Athera Biotechnologies AB
 Athera Biotechnologies AB Pharmaceuticals: MajorHealth Technology Provides anti-inflammatory biological candidate drugs | Health Technology |
Medivir AB
 Medivir AB Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
AstraZeneca AB
 AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services Researches and develops pharmaceutical products | Commercial Services |
Industrifonden
 Industrifonden Investment ManagersFinance Industrifonden invests in companies located in the Nordic region. The firm targets companies operating in the fields of planetary health, life science, deep tech and transformative tech. It provides financing for seed and early stage capital requirements with an investment size of SEK 10 – 50 million. | Finance |
Biovitrum AB
 Biovitrum AB Miscellaneous Commercial ServicesCommercial Services Develops pharmaceuticals and conducts medical research services | Commercial Services |
Karolinska Development AB (Private Equity)
 Karolinska Development AB (Private Equity) Investment ManagersFinance Karolinska Development seeks investment in companies located in the Nordic region, primarily in Swedish. The firm targets companies operating in the fields of health technology, health services, medical devices, technology services, life science. It provides financing for early stage capital requirements. It takes a seat on the board of directors. | Finance |
Flerie AB
 Flerie AB Pharmaceuticals: MajorHealth Technology Discovers and develops drugs for the treatment of inflammation and cancer diseases | Health Technology |
Arexis AB
 Arexis AB Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
Calliditas Therapeutics AB
 Calliditas Therapeutics AB Pharmaceuticals: MajorHealth Technology Develops and commercializes pharmaceutical products | Health Technology |
Umea Universitet
 Umea Universitet Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Uminova Invest AB
 Uminova Invest AB Investment ManagersFinance Uminova Invest specializes in seed capital investing. The firm invests exclusively in high-growth projects and businesses with a clear connection to Umeå University or other academic entities and research institutes in the province of Västerbotten, where Umeå is located. Uminova Invest targets science-based projects with unique selling points and significant market potential, in sectors such as biotechnology, IT and medical technology. The firm acquires minority stakes and typically co-invests with their shareholding institutions. In addition to capital they actively contribute business know-how, management support, marketing expertise and access to their network of contacts. They invest primarily in early-stage companies, and may invest during the growth phase as well. Although they aim to exit their investments after three years once their portfolio companies have an established market, Uminova Invest may retain their stake over the longer term. Their preferred exit strategy is through resale, either to the founder or to existing shareholders. | Finance |
Nanoxis AB
 Nanoxis AB Miscellaneous Commercial ServicesCommercial Services Provides tools and services for membrane protein research | Commercial Services |
OxThera AB
 OxThera AB Medical/Nursing ServicesHealth Services Develops novel treatments for hyperoxaluria leading to kidney damage and potential organ failure | Health Services |
Medtentia AB
 Medtentia AB Medical SpecialtiesHealth Technology Provides medical devices for cardiac valve surgery | Health Technology |
Lund University Bioscience AB
 Lund University Bioscience AB Investment ManagersFinance LU Bio's investment objective is to create value growth in their innovations for all stakeholders such as the inventors, Lund University, investors and society. Their investment strategy seeks to invest in start-up, early-stage or early-expansion phase projects in the life science field which require capital. They invest across the Nordic region of Sweden, Denmark, Finland and Norway, with a particular focus on Sweden. LU Bio is an active investment partner. They provide both capital and industrial development know-how with the goal of accelerating efficient development of life science innovations. They look to develop high-growth, high-technology and focused portfolio firms. The firm aims to grow defensible and dominant market positions. | Finance |
Avaris AB
 Avaris AB Miscellaneous Commercial ServicesCommercial Services Provides cancer therapies based on gen- and cell-therapy | Commercial Services |
PharmaSurgics In Sweden AB
 PharmaSurgics In Sweden AB Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
Kabigen AB | |
HVR Cardio Oy (Finland)
HVR Cardio Oy (Finland) Medical SpecialtiesHealth Technology Develops medical solutions for mitral valve repair | Health Technology |
Karolinska Development AB
 Karolinska Development AB Financial ConglomeratesFinance Operates as a life sciences investment company | Finance |
Symbicom AB | |
InDex Diagnostics AB
InDex Diagnostics AB Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Beacon Software, Inc. /NY/
Beacon Software, Inc. /NY/ Packaged SoftwareTechnology Services Develops software for transportation agencies | Technology Services |
Airsonett Holding AB | |
Sixera Pharma AB
Sixera Pharma AB Pharmaceuticals: GenericHealth Technology Conducts research and development of pharmaceuticals treatment for Netherton syndrome | Health Technology |
InDex Pharmaceuticals AB
InDex Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Ignitus AB | |
Cinclus Pharma AG
 Cinclus Pharma AG BiotechnologyHealth Technology Operates as a research based biotech company | Health Technology |
Malmö Industrifinans AB
 Malmö Industrifinans AB Investment Banks/BrokersFinance Engages in buying and selling of shares | Finance |
Cinclus Pharma Holding AB
 Cinclus Pharma Holding AB BiotechnologyHealth Technology Operates as a holding company through its subsidiaries develops small molecules for treatment of gastric acid related diseases | Health Technology |
QureTech Bio AB |
